Skip to main navigation Skip to search Skip to main content

Development and application of a drug screen for compounds targeting phenotypic deficits associated with mutation of SORT1 in a human neuronal-based model of dementia

Project Details

StatusFinished
Effective start/end date1/10/22 → 30/04/26

Funding

  • Chief Scientist Office: £4,240.95
  • Chief Scientist Office: £370,592.55